| 2026-08-05 | Press release | Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates |
| 2026-07-21 | Press release | Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Acr |
| 2026-07-17 | Press release | Immuneering Corporation Announces Grants of Inducement Awards |
| 2026-06-15 | Press release | Immuneering Appoints Andrew Gengos as Chief Financial Officer |
| 2026-06-11 | Press release | Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pa |
| 2026-06-01 | Press release | Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemot |
| 2026-05-21 | Press release | Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with |
| 2026-05-15 | Press release | Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates |
| 2026-04-21 | Press release | Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in |
| 2026-04-20 | Press release | Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Sup |
| 2026-04-06 | Press release | Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-03-06 | Press release | Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates |
| 2026-03-02 | Press release | Immuneering to Present at the Leerink Global Healthcare Conference |
| 2026-02-18 | Press release | Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference |
| 2026-01-07 | Press release | Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated wit |
| Press release | Earnings Release |
| Press release | Earnings Release |
| Press release | Earnings Release |
| Press release | Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates |
| 2024-11-13 | Press release | Earnings Release |
| 2024-08-06 | Press release | Earnings Release |
| 2024-05-07 | Press release | Earnings Release |
| 2024-03-01 | Press release | Earnings Release |
| 2023-11-09 | Press release | Earnings Release |
| 2023-08-03 | Press release | Earnings Release |
| 2023-05-04 | Press release | Earnings Release |
| 2023-03-06 | Press release | Earnings Release |
| 2022-11-10 | Press release | Earnings Release |
| 2022-08-10 | Press release | Earnings Release |
| 2022-05-10 | Press release | Earnings Release |
| 2022-03-10 | Press release | Earnings Release |
| 2021-11-09 | Press release | Earnings Release |
| 2021-09-09 | Press release | Earnings Release |